SCHEMBL482624

SCHEMBL482624

CC(C)C1CCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10030794 1.00
SCHEMBL12119805 1.00
SCHEMBL10323326 0.92
SCHEMBL12384257 0.92
SCHEMBL943444 0.92
SCHEMBL15624974 0.90 SLC6A3 (0.37)
SCHEMBL777224 0.85
SCHEMBL801070 0.85
SCHEMBL777278 0.85
SCHEMBL1188560 0.83 HPGD (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 830 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260091011-A1 HYDROALCOHOLIC SINGLE PHASE GEL COMPOSITIONS FOR TOPICAL DELIVERY OF DICLOFENAC HALEON CH SARL (CH) 2026-04-02 US claimed
CN-120201994-A Hydroalcoholic single phase gel compositions for topical delivery of diclofenac 赫力昂消费者保健有限责任公司 2025-06-24 CN claimed
WO-2024062348-A1 HYDROALCOHOLIC SINGLE PHASE GEL COMPOSITIONS FOR TOPICAL DELIVERY OF DICLOFENAC HALEON CH SARL (CH) 2024-03-28 WO claimed
EP-4342449-A1 HYDROALCOHOLIC SINGLE PHASE GEL COMPOSITIONS FOR TOPICAL DELIVERY OF DICLOFENAC Haleon CH SARL (CH) 2024-03-27 EP claimed
EP-2202577-B1 Chemically amplified positive resist composition and resist patterning process SHINETSU CHEMICAL CO (JP) 2014-08-27 EP claimed
US-6017889-A Metalloproteinase inhibitors BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 2000-01-25 US claimed
EP-0740655-B1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARM (GB) 1999-10-20 EP claimed
US-5902791-A TREATING RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, PERIODONTAL DISEASE, GINGIVITIS, CORNEAL ULCERATION OR TUMOR METASTASES BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1999-05-11 US claimed
EP-0740655-A1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1996-11-06 EP claimed
WO-1995019961-A1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1995-07-27 WO claimed
US-20260091011-A1 HYDROALCOHOLIC SINGLE PHASE GEL COMPOSITIONS FOR TOPICAL DELIVERY OF DICLOFENAC HALEON CH SARL (CH) 2026-04-02 US disclosed
US-12522720-B2 Modified conjugated diene-based polymer, method for preparing the same and rubber composition including the same LG CHEM, LTD. (KR) 2026-01-13 US disclosed
CN-120201994-A Hydroalcoholic single phase gel compositions for topical delivery of diclofenac 赫力昂消费者保健有限责任公司 2025-06-24 CN disclosed
EP-4493573-A1 COMPOUNDS AND METHODS FOR TREATING DISEASE Rome Therapeutics, Inc. (US) 2025-01-22 EP disclosed
CN-114846068-B Tire with a tire body 株式会社普利司通 2024-10-25 CN disclosed
WO-1997019050-A1 SYNTHESIS OF CARBOXYLIC ACID DERIVATIVES BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1997-05-29 WO disclosed
EP-0740655-A1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1996-11-06 EP disclosed
WO-1995019961-A1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1995-07-27 WO disclosed
US-4005126-A Preparation of haloalkyl esters UNIVERSAL OIL PRODUCTS COMPANY (US) 1977-01-25 US disclosed
US-4005125-A Preparation of haloalkyl esters UNIVERSAL OIL PRODUCTS COMPANY (US) 1977-01-25 US disclosed